Compugen Ltd

CGENNASDAQ • USD
ThemeHealthcare - Oncology›Immunotherapy & Immuno-Oncology
2.10 USD
↘ 0.12 (5.41%)AT CLOSE (11:59 AM EDT)
2.15
↗ 0.05 (2.57%)
POST MARKET (AS OF 06:37 PM EDT)
Post Market
AS OF 06:37 PM EDT
2.15
↗ 0.05 (2.57%)
🔴Market: CLOSED
Open?$2.19
High?$2.20
Low?$2.07
Prev. Close?$2.22
Volume?242.6K
Avg. Volume?N/A
VWAP?$2.12
Bid / Ask
Bid?$1.99 × 100
Ask?$2.09 × 100
Spread?$0.10
Midpoint?$2.04
Valuation & Ratios
Market Cap?198.6M
Shares Out?N/A
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A

Shares of Compugen Ltd (CGEN) are trading at $2.10. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9 and a bullish Golden Cross on the moving averages.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.
Themes
Healthcare - Oncology›Immunotherapy & Immuno-OncologyAI & Machine Learning›AI-Powered Analytics & Decision Systems
Employees
75
Market Cap
198.6M
Industry
N/A
Website
www.cgen.com
Listed
2000-08-11
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
2
Momentum?
50
Short Sent.?
30
Piotroski F-Score?0/9Weak
Altman Z-Score?-0.31Distress
Confidence?45%Low
Full Fundamental Analysis →
Short InterestModerate
Short Interest?1.7M
Days to Cover?3.8
Avg Daily Volume447.6K
Settlement Date2026-05-15
MarketsMoversWatchlist